Events and congress contributions – MukoCell 2018
Events and congresses contributions on the subject of urethral reconstruction (urethroplasty) with MukoCell®
DetailsA New Milestone in Urology
Authors: Prof. Guido Barbagli, Dr. med. Gouya Ram-Liebig Native oral mucosa is implanted since many years as graft for urethroplasty. However, its excision from the mouth may be associated with potential complications and morbidities at oral site. Early complications include pain, numbness, bleeding, and infection while longer-term complications comprise oral tightness and restriction of…
DetailsClinical Experience with Urethral Reconstruction
The ready availability of tissues and organs to replace and repair those that have been damaged is an important clinical need. The field of tissue engineering might offer an innovative solution.
DetailsRegulatory challenges for autologous tissue engineered products
In Europe TEPs, somatic cell therapy medicinal products, and gene therapy medicinal products are summarised under the term advanced therapy medicinal products (ATMP) [1,2]. TEPs contain viable autolo- gous, allogenic or xenogenic cells.
DetailsReconstruction of the urethra with MukoCell
The following publication shows the development of the first urology tissue engineering product starting from preclinic to market approval in Germany:
DetailsAUA 2014 – SESSION: TRAUMA/RECONSTRUCTION: TRAUMA & RECONSTRUCTIVE SURGERY III
Abstract MP9-04: Preclinical and clinical examination of tissue-engineered graft for urethral reconstruction (MukoCell®) with regard to its safety
DetailsCertification of quality and pre-clinical data of MukoCell by the EMA
The quality and pre-clinical data of our lead product MukoCell have been certified by the European Medicines Agency (EMA).
Details